Guidance on the use of temozolomide for the treatment of recurrant malignant glioma (brain cancer)
By: National Institute for Clinical Evidence.
Series: Technology appraisal guidance -- no.33
Publisher: National Institute for Clinical Excellence
Published: 2001
Place of publication: London
Language: eng
Number of pages: 15